Human serum Zn-alpha2-glycoprotein in amniotic fluid.

Area of Science:

• Biochemistry
• Reproductive Biology
• Clinical Chemistry

Background:

• Human serum Zn-alpha2-glycoprotein (Zn-alpha2-GP) is a protein found in maternal circulation.
• The presence and role of Zn-alpha2-GP in amniotic fluid are not well understood.

Purpose of the Study:

• To quantify Zn-alpha2-GP in human amniotic fluid.
• To investigate the relationship between amniotic fluid Zn-alpha2-GP and maternal serum levels.
• To explore the correlation of amniotic fluid Zn-alpha2-GP with gestational age and amniotic fluid total protein.

Main Methods:

• Measurement of Zn-alpha2-GP concentrations in maternal serum and amniotic fluid.
• Quantification of total protein in amniotic fluid and maternal serum.
• Statistical analysis to determine correlations and relationships between measured parameters.

Main Results:

• Mean amniotic fluid Zn-alpha2-GP concentration was 0.98 +/- 0.40 mg/100 ml, approximately one-tenth of maternal serum levels (9.65 +/- 1.18 mg/100 ml).
• Amniotic fluid Zn-alpha2-GP concentration correlated with amniotic fluid total protein and, approximately, with maternal serum Zn-alpha2-GP.
• No significant correlation was found between maternal serum Zn-alpha2-GP and maternal serum total protein, nor between amniotic fluid total protein and maternal serum total protein.
• Both amniotic fluid Zn-alpha2-GP and total protein increased during gestation, peaking at the end of the second trimester.

Conclusions:

• Zn-alpha2-GP is present in human amniotic fluid at significantly lower concentrations than in maternal serum.
• Amniotic fluid Zn-alpha2-GP levels appear to be influenced by gestational progress and amniotic fluid protein content.
• The precise origin and functional significance of Zn-alpha2-GP within the amniotic fluid remain undetermined and warrant further investigation.